Showing results (21-30 of 149) with videos related to
Sort By:
Pageof 15
The Annals of Pharmacotherapy|September 1, 1992
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.Alzheimer Disease and Associated Disorders|January 1, 1995
Orthostasis in Alzheimer disease: a retrospective analysisS S Jhee, J J Sramek, T S Wardle, et al.The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.Journal of Geriatric Psychiatry and Neurology|October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.Depression and Anxiety|June 5, 1999
Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxietyJ J Sramek, W W Hong, S Hamid, et al.Life Sciences|March 6, 1998
A bridging study of LU 25-109 in patients with probable Alzheimer's diseaseJ J Sramek, M Forrest, H Mengel, et al.The Annals of Pharmacotherapy|April 1, 1992
Detection of benzodiazepines in human hair by radioimmunoassayJ J Sramek, W A Baumgartner, T N Ahrens, et al.Psychopharmacology Bulletin|January 1, 1993
The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trialN R Cutler, J J Sramek, T S Wardle, et al.The Annals of Pharmacotherapy|December 10, 1997
Ethnicity and antipsychotic responseE J Frackiewicz, J J Sramek, J M Herrera, et al.Alzheimer Disease and Associated Disorders|January 7, 1999
Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB)A E Veroff, N C Bodick, W W Offen, et al.Pageof 15